Defunct Company
Total Trials
23
As Lead Sponsor
20
As Collaborator
3
Total Enrollment
2,358
NCT00626769
Third Year Evaluation on Genistein Efficacy and Safety
Phase: N/A
Role: Collaborator
Start: Jul 31, 2005
Completion: Sep 30, 2006
NCT00294125
Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
Phase: Phase 1
Start: Feb 28, 2006
Completion: Nov 30, 2007
NCT00303017
Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study
Role: Lead Sponsor
Start: Mar 31, 2006
NCT00928837
Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
Completion: Sep 30, 2007
NCT00435292
Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
Start: Apr 30, 2006
Completion: Dec 31, 2007
NCT00790985
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
Start: Jan 31, 2008
Completion: Aug 31, 2008
NCT02582424
Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.
Start: Jul 31, 2012
Completion: Sep 30, 2013
NCT01947491
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
Phase: Phase 3
Start: Nov 30, 2013
Completion: Jan 31, 2015
NCT01967069
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
Completion: Jul 31, 2014
NCT02070965
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
Phase: Phase 2
Start: Jan 31, 2014
Completion: Oct 31, 2014
NCT02361437
Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin Ulcers
Start: Feb 28, 2015
Completion: Oct 31, 2015
NCT02527421
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Start: Aug 19, 2015
Completion: Mar 30, 2019
NCT02683408
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Start: Feb 29, 2016
Completion: Jul 31, 2017
NCT02749799
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Phase: Phase 4
Completion: Aug 31, 2016
NCT02936271
Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting
Start: Oct 31, 2016
Completion: Apr 1, 2017
NCT03179605
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Start: May 2, 2017
Completion: Jun 3, 2020
NCT03558958
Safety and Efficacy of P-188 NF in DMD Patients
Start: Aug 8, 2018
Completion: Sep 1, 2021
NCT05616962
Vasculera in Participants With Lipedema
Start: May 26, 2019
Completion: Sep 23, 2019
NCT04793711
EpiCeram for Skin Protection in Healthcare Workers
Start: Mar 15, 2021
Completion: Jul 1, 2021
NCT06157177
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Start: Nov 15, 2023
Completion: Nov 15, 2025
NCT06382662
Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition
Start: Apr 29, 2024
Completion: Mar 6, 2025
NCT06348303
Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg
Start: May 16, 2024
Completion: Oct 30, 2024
NCT06256575
Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Start: May 2, 2025
Completion: Aug 15, 2027